Surims Ltd Logo
 
 
 
 
 
 

Search the global news on our network companies

A comprehensive source of news from our network. With the latest from companies appearing on our platform, around the globe, we deliver an extensive summary of news, press releases and information directly from the companies and other authoritative industry news sources.

Search and filter the results by company or location to find the news that matters to you.

If you would like to publish news on behalf of your company, please register with us at the following link  https://www.pharmaservicesdirectory.com/register  

 
Search Term
 
 
Sector
 
 
Country
 
 

Save This Search | View as Grid | Order by Recently Added | Order by Company Name

  • Total Results: 916
  • Total Pages: 115
 
 
 
Probiogen Logo
 
Probiogen - 28 Mar 2024
 
ProBioGen, a CDMO, proudly announces a partnership with DIOSynVax Ltd to manufacture a new vaccine
 
ProBioGen, a globally recognized and experienced Contract Development & Manufacturing Organization (CDMO), proudly announces a partnership with DIOSynVax Ltd to manufacture DIOS-HFVac3, a trivalent hemorrhagic fever (HF) vaccine that was developed in collaboration with Prof. Wagners team (Molecular Virology, Institute of Medical Microbiology and Hygiene, University of Regensburg). The novel vaccine targets HF diseases caused by Ebola, Marburg, and Lassa viruses. Epidemics of viral hemorrhagic fevers are a major public health concern and a major economic burden. Especially…
 

Read more on this story »

Manage Your Profile
 
Primrose Bio Logo
 
Primrose Bio - 28 Mar 2024
 
Intravacc and Primrose Bio Announce Partnership to Enhance Conjugate Vaccine Development
 
BILTHOVEN, The Netherlands, March 28, 2024 (GLOBE NEWSWIRE) -- Intravacc, a leading global contract development and manufacturing organization (CDMO) specializing in infectious disease and therapeutic vaccines, and Primrose Bio, a biotechnology company with leading technologies that improve the manufacturing of next-generation therapeutics, announced a strategic partnership to enhance the development and supply of conjugate vaccines. Third parties engaged in developing conjugate vaccines will have access to a seamless solution for vaccine conjugation, manufacturing…
 

Read more on this story »

Manage Your Profile
 
InveniAI Logo
 
InveniAI - 27 Mar 2024
 
InveniAI Announces Collaboration with Ono Pharmaceutical for Target Discovery
 
Guilford, Conn. – February 19, 2024 – InveniAI LLC, a global leader in the application of artificial intelligence (AI) and machine learning (ML) tools to revolutionize drug discovery and development, announces a strategic collaboration with Ono Pharmaceutical Co., Ltd. (Ono), a renowned pharmaceutical company committed to advancing innovative solutions for unmet medical needs. InveniAI's cutting-edge technology, including powerful AI and ML algorithms and Generative AI tools, powers its flagship platform AlphaMeld, which has consistently demonstrated the ability…
 

Read more on this story »

Manage Your Profile
 
Closed Loop Medicine Logo
 
Closed Loop Medicine - 27 Mar 2024
 
TEVA UK AND CLOSED LOOP MEDICINE ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE DEVELOPMENT OF PERSONALISED MEDICINES
 
Castleford and London, UK: Teva UK Limited and Closed Loop Medicine Ltd have announced a strategic partnership to advance the development of personalised medicine. Under the agreement, Closed Loop Medicine – a leading TechBio company – and pharmaceutical company, Teva UK, will investigate opportunities to use Closed Loop Medicine’s proprietary software as a medical device (SaMD) technology platform which aims to advance the development of personalised medicines, improve drug efficacy and outcomes in patients with specific chronic disorders by combining…
 

Read more on this story »

Manage Your Profile
 
Caring Cross Logo
 
Caring Cross - 27 Mar 2024
 
Brazil aims to manufacture its own cell therapies — at a fraction of the current cost
 
Brazil’s Ministry of Health is working with a US nonprofit to locally manufacture CAR-T therapies and potentially other cell and gene therapies at a much lower cost. The goal is to provide cell therapy free of charge to patients while charging Brazil’s health system around $35,000 a dose, which is roughly one-tenth of the cost in Europe and an even smaller fraction of US costs. Caring Cross is providing the technology and training to manufacture CAR-T therapies to Fiocruz. Fiocruz is compensating Caring Cross for the tech transfer, while materials are provided…
 

Read more on this story »

Manage Your Profile
 
Batavia Biosciences B.V. Logo
 
 
Batavia and Candel collaborate to develop therapeutics against glioma brain tumors
 
Woburn, MA, March 21, 2024 — Today, Batavia Biosciences, a leading Contract Development and Manufacturing Organization, announces a new partnership with Candel Therapeutics, Inc. (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer. The collaboration aims to accelerate the development and production of CAN-3110, an oncolytic viral immunotherapy for glioma brain tumors, based on a replication attenuated Herpes Simplex Virus (HSV). 
 

View original story »

Manage Your Profile
 
Biocytogen Pharmaceuticals (Beijing) Co Logo
 
 
Biocytogen Enters Collaboration with ABL Bio to Develop New Bispecific Antibody-Drug Conjugates
 
Biocytogen Enters Collaboration with ABL Bio to Develop New Bispecific Antibody-Drug Conjugates 2024.03.25   Beijing, China, March 25, 2024 - Biocytogen Pharmaceuticals…
 

Read more on this story »

Manage Your Profile
 
bioXcelerate Logo
 
bioXcelerate - 25 Mar 2024
 
bioXcelerate launches breakthrough AI tool for faster drug discovery
 
bioXcelerate, a new and innovative health data science division of Optima Partners Limited, has revealed a new groundbreaking AI tool, which is set to accelerate the process for identifying and developing new drugs. The tool, known as PleioGraph, can analyze complex medical data 100 times faster than existing state-of-the-art methods used to detect biological networks which explain disease risk and inform drug discovery.
 

View original story »

Manage Your Profile
 
 
  • Total Results: 916
  • Total Pages: 115
 
 

Network News

Keeping the latest and up-to-date news on our companies is a key activity of the editorial team.

We support companies directly through the profiles to allow them update their profile with the latest news and company announcements. Search fields are provided so that you can access news by company name, sector e.g research, manufacturing, equipment, packaging or geography. 

The global news is updated daily and its aim is to provide you as a directory user with the information needed to make good buying or supply choices. News covers companies operating within the pharmaceutical, biotechnology, medical device and nutraceutical sectors. 

Also through our software applications you can evaluate, rate and score news and company announcements to support corporate risk management activities. Through the software applications it is possible to supplement and add your own news items, keeping a library of news activities on any company identified through the directory. 

Take the Next Step

Should you have any questions or require further information please contact us ...
Contact the support team »

Check if your company is listed and claim your online profile ...
Search for your company listing »

If you're not listed in the directory and you want to build a public profile, register for an account ...
Register for an account to build a profile »

Apply for a free trial of our Supplier Management Software ...
Register for an account to trial the software »

 
 
 
 
 
 
 

About Us

The Partnership Tree established in 2003 (initially a pharmaceutical company directory) supporting companies in the finding, qualification and management of quality vendors and technical partners in the pharmaceutical. biotech and medical devices industry.

The Partnership Tree supports the finding and egagement with technical and commercial partners. It also incorporates software applications that support successful partner engagement and management. These include the building and deployment of questionnaires and assessments for vendor qualification, document excahnge, electronic signatures and sign-offs and project management between vendor/partner and customer.

Access to the features and software is available on a 'pay as you go' basis, or a customised version can be licensed for your company for its own on-boarding and supplier management activities. Further information on our software services can be found at www.thepartnersplatform.com 

 
 
 

Get in Touch

The Partnership Tree   paul@thepartnersplatform.com

 
 

© 2024 Surims Ltd | All Rights Reserved.